avail
monoclon
antibodi
mab
specif
sarscoronaviru
sarscov
import
develop
diagnost
tool
treatment
infect
molecular
character
nine
monoclon
antibodi
rais
immun
mice
use
highli
purifi
inactiv
sarscov
inocul
antigen
present
report
antibodi
specif
numer
viral
protein
target
six
abl
effect
neutral
sarscov
vitro
includ
one
neutral
titr
nm
phylogenet
analysi
heavi
light
chain
sequenc
reveal
mab
share
consider
homolog
major
heavi
chain
belong
singl
ig
germlin
vgene
famili
consider
sequenc
variat
evid
light
chain
sequenc
analys
demonstr
neutral
abil
correl
specif
murin
v
h
gene
allel
instanc
one
evid
trend
high
sequenc
conserv
v
h
chain
neutral
mab
particularli
result
suggest
optim
murin
mab
neutral
sarscov
infect
like
possibl
aid
develop
diagnost
tool
passiv
treatment
sarscov
infect
abbrevi
cdr
complementar
determin
region
cov
coronaviru
divers
fca
freund
complet
adjuv
fia
freund
incomplet
adjuv
fr
framework
ig
immunoglobulin
ip
intraperiton
j
join
pb
phosphat
buffer
salin
sar
sever
acut
respiratori
syndrom
sc
subcutan
v
h
variabl
region
heavi
chain
v
l
variabl
region
light
chain
correspond
author
infect
peopl
variou
countri
worldwid
caus
approxim
death
drosten
et
al
b
http
wwwwhointcsrsarscountryen
whole
genom
sarscov
isol
implic
outbreak
toronto
sequenc
character
marra
et
al
rota
et
al
character
viru
continu
phenomen
rate
understand
function
numer
viral
protein
phylogeni
sarscov
viral
life
cycl
continu
grow
review
stadler
et
al
eickmann
et
al
thiel
et
al
current
effect
vaccin
treatment
sarscov
infect
avail
effect
vaccin
develop
best
hope
treatment
infect
prevent
control
futur
outbreak
remain
develop
passiv
immunotherapi
sarscovspecif
antibodi
holm
suggest
protect
might
afford
passiv
immunotherapi
concentr
sarscovspecif
igg
antibodi
li
et
al
report
establish
infect
individu
benefit
treatment
serum
recov
patient
pearson
et
al
recent
also
report
viral
replic
inhibit
lower
respiratori
tract
mice
underw
passiv
immun
neutral
antibodi
present
immun
serum
deriv
infect
mice
subbarao
et
al
monoclon
antibodi
develop
human
nonimmun
singl
chain
variabl
region
scfv
librari
also
shown
neutral
sarscov
vitro
strengthen
argument
passiv
immunotherapi
highli
specif
mab
might
effect
control
sarscov
infect
sui
et
al
product
mab
specif
sarscov
vital
studi
viral
pathogenesi
develop
diagnost
tool
vaccin
sinc
develop
serum
antibodi
infect
sarscov
take
week
li
et
al
assay
accur
detect
presenc
viral
nucleic
acid
protein
may
prefer
rapid
diagnosi
sarscov
infect
profil
antibodi
respons
sarscov
well
establish
li
et
al
analys
also
identifi
viral
protein
might
serv
best
marker
immunolog
detect
infect
sarscov
tan
et
al
lu
et
al
similarli
character
immunogen
peptid
deriv
sarscov
structur
protein
also
allow
identif
epitop
recogn
antibodi
present
patient
serum
knowledg
develop
mab
use
diagnost
assay
clinic
treatment
attain
goal
herein
character
immunogenet
neutral
endpoint
purifi
murin
hybridomaderiv
mab
rais
mice
use
highli
purifi
sarscov
inocul
antigen
numer
report
exist
character
antibodi
rais
surrog
sarscov
immunogen
exampl
includ
polyclon
antibodi
rais
peptid
recombin
sarscov
nucleoprotein
chang
et
al
lin
et
al
monoclon
antibodi
rais
sarscovderiv
recombin
protein
fragment
zhou
et
al
similarli
neutral
mab
specif
spike
protein
deriv
human
phage
display
librari
develop
character
sui
et
al
littl
publish
mab
develop
nativ
viral
particl
relev
immunogenet
characterist
panel
nine
murin
mab
rais
whole
sarscov
six
effect
neutral
viru
vitro
present
develop
provid
distinct
advantag
search
effect
passiv
immun
therapi
mab
rais
intact
viru
rather
individu
viral
protein
immunogen
peptid
procedur
employ
product
sarscov
discuss
detail
berri
et
al
briefli
sarscov
strain
krokhin
et
al
expand
plaqu
purif
cell
monolay
partial
purifi
sucros
cushion
purifi
use
iodixanol
gradient
centrifug
fraction
test
western
immunoblot
convalesc
patient
serum
fraction
react
sarscov
pool
dialyz
phosphat
buffer
salin
pb
concentr
ultracentrifug
h
g
result
highli
purifi
whole
viru
particl
procedur
employ
product
hybridoma
mab
discuss
detail
berri
et
al
briefli
femal
balbc
mice
charl
river
wilmington
inject
subcutan
sc
g
betapropiolactoneinactiv
sarscov
strain
equal
part
freund
complet
adjuv
fca
difco
bd
oakvil
thirti
day
later
mice
receiv
g
sarscov
sc
freund
incomplet
adjuv
fia
total
volum
l
mice
receiv
g
antigen
total
volum
l
sc
fia
day
mice
receiv
final
booster
inocul
intraperiton
ip
g
highli
purifi
sarscov
l
pb
day
euthan
anesthesia
overdos
spleen
remov
subsequ
hybridoma
fusion
hybridoma
fusion
establish
stabl
clone
hybridoma
supernat
screen
via
elisa
use
purifi
sarscov
target
antigen
isotyp
commerci
murin
isotyp
dipstick
test
roch
facilit
select
appropri
primer
subsequ
rtpcr
monoclon
antibodi
produc
medium
scale
cm
steril
dispos
roller
bottl
flask
corn
roller
bottl
contain
ml
complet
hybridoma
media
bdquantum
yield
vwr
canada
fetal
bovin
serum
wisent
montreal
biogrohybridoma
serumfre
supplement
biogro
technolog
winnipeg
inocul
ml
hybridoma
cell
final
concentr
million
viabl
cellsml
achiev
cultur
allow
grow
extinct
harvest
day
postinocul
supernat
clarifi
remov
cell
mass
centrifug
concentr
amicon
stir
cell
ultrafiltrationnitrogen
concentr
vwr
canada
millipor
usa
membran
individu
membran
use
concentr
mab
concentr
supernat
mix
protein
abind
buffer
pierc
purifi
equilibr
ml
protein
gsepharos
column
amersham
biotech
per
manufactur
instruct
elut
antibodi
dialyz
remov
salt
use
centriprep
centrifug
filter
unit
millipor
kda
cutoff
mab
solut
filter
steril
lowproteinbind
syring
filter
vwr
protein
concentr
determin
use
microbca
assay
pierc
igg
concentr
standard
mgml
steril
pb
gibco
sarscov
vitro
neutral
assay
perform
essenti
describ
berri
et
al
follow
modif
panel
purifi
mab
steril
filter
sampl
standard
concentr
mgml
igg
subject
serial
dilut
incub
live
sarscov
approxim
million
mabsecret
hybridoma
cell
collect
homogen
via
passag
needl
use
rnasefre
ml
syring
total
rna
isol
use
rneasi
mini
spin
kit
accord
manufactur
instruct
qiagen
cdna
produc
via
revers
transcript
use
pg
g
rna
templat
base
oligodt
primer
superscript
ii
revers
transcriptas
invitrogen
reaction
incub
c
h
follow
inactiv
revers
transcriptas
c
min
rna
remov
reaction
incub
rnaseh
invitrogen
c
min
result
cdna
use
templat
pcr
amplif
use
taq
polymeras
invitrogen
variou
primer
specif
v
h
v
l
gene
primer
use
follow
orient
describ
detail
elsewher
berri
barba
et
al
dattamajumdar
et
al
degener
nucleotid
indic
follow
b
c
g
g
deoxyinosin
k
g
c
r
g
c
g
w
c
pcr
reaction
incub
c
min
follow
cycl
c
c
c
min
final
extens
c
min
complet
reaction
approxim
g
pcr
product
resolv
agaros
gel
stain
ethidium
bromid
pcr
product
appropri
size
basepair
insert
invitrogen
tm
vector
transform
cell
accord
manufactur
instruct
coloni
contain
plasmid
insert
select
overnight
growth
c
luriabertani
agar
plate
contain
ampicillin
gml
xgal
gml
white
posit
coloni
incub
ml
luriabertani
broth
contain
ampicillin
gml
h
vigor
shake
c
plasmid
isol
use
qiaprep
spin
miniprep
dna
isol
kit
accord
manufactur
instruct
qiagen
ecori
digest
g
result
plasmid
resolut
product
via
agaros
gel
electrophoresi
describ
confirm
presenc
appropri
size
insert
one
put
posit
clone
sequenc
taa
tac
gac
tca
cta
tag
cag
gaa
aca
gct
atg
primer
use
abi
prism
bigdy
tm
termin
cycl
sequenc
kit
abi
prism
genet
analyz
consensu
sequenc
gener
use
dnastar
softwar
suit
dnastar
inc
genbank
access
number
v
h
sequenc
v
l
sequenc
present
work
consensu
nucleotid
sequenc
compar
mu
musculu
immunoglobulin
ig
set
databas
use
imgtvquest
lefranc
http
imgtcin
frhomehtml
sequenc
concurr
compar
musculu
ig
germlin
vgene
databas
use
igblast
altschul
et
al
http
wwwncbinlmnih
govigblast
allow
identif
complementar
determin
region
cdr
framework
fr
region
v
h
v
l
sequenc
provid
number
infer
amino
acid
sequenc
accord
kabat
et
al
similarli
igblast
result
allow
identif
close
relat
murin
ig
germlin
vgene
current
avail
databas
case
entir
sequenc
includ
end
sequenc
impos
specif
primer
use
origin
pcr
amplif
examin
infer
amino
acid
sequenc
trim
remov
residu
encod
primer
region
elimin
potenti
artefactu
match
caus
primer
employ
pcr
amplif
heavi
light
chain
sequenc
align
clustalw
thompson
et
al
http
clustalwgenomeadjp
use
standard
paramet
gap
open
penalti
gap
extens
penalti
weight
transit
hydrophil
gap
allow
weight
matrix
blosum
align
analyz
use
genedoc
version
nichola
et
al
produc
textual
align
quantifi
related
sequenc
analys
perform
use
bioedit
version
hall
mega
version
softwar
suit
kumar
et
al
amino
acid
sequenc
examin
sequenc
align
via
clustalw
describ
analyz
via
neighbor
join
analysi
bootstrap
use
replic
human
mab
sui
et
al
v
h
genbank
access
v
l
genbank
access
initi
use
outlier
sequenc
mab
chosen
specif
sarscov
spike
protein
neutral
sar
infect
vitro
develop
nonimmun
human
sin
gle
chain
variabl
fragment
scfv
librari
second
outlier
also
human
origin
found
follow
v
l
v
h
amino
acid
sequenc
compar
human
ig
sequenc
ncbi
databas
use
igblast
describ
chosen
potent
sar
neutral
murin
mab
isol
specif
spike
human
antibodi
chosen
ensur
similar
would
minim
consid
mous
inde
human
antibodi
inher
share
consider
homolog
regardless
specif
sequenc
show
lowest
homolog
v
h
v
l
sequenc
chosen
follow
v
l
genbank
access
level
ident
amino
acid
v
h
genbank
access
level
ident
amino
acid
phylogenet
analys
human
sequenc
clearli
serv
effect
outlier
includ
relev
figur
tabl
summar
relev
characterist
murin
mab
gener
highli
purifi
inactiv
sarscov
examin
v
h
chain
two
ig
vgene
famili
repres
eight
nine
mab
share
high
sequenc
ident
vgene
famili
remain
mab
share
high
sequenc
ident
gene
vgene
famili
member
five
eight
mab
close
relat
vgene
set
five
mab
neutral
sarscov
vitro
mab
close
relat
vgene
respect
close
relat
closer
analysi
v
h
chain
mab
share
signific
homolog
vgene
present
fig
tabl
align
nucleotid
sequenc
v
h
sequenc
reveal
high
level
ident
fig
similarli
amino
acid
level
sequenc
share
consider
ident
amongst
vgene
fig
mutat
away
germlin
sequenc
typic
immunoglobulin
vgene
cdna
level
ident
pairwis
express
number
ident
residuestot
number
residu
percent
ident
residu
tdepend
b
cell
respons
fish
manser
quantif
level
ident
sequenc
summar
tabl
analysi
jgene
show
three
j
h
gene
repres
v
h
chain
rel
even
distribut
appear
slight
bia
toward
j
h
four
mab
j
h
three
mab
j
h
two
mab
also
repres
tabl
analysi
sequenc
reveal
h
region
present
seven
nine
mab
homolog
numer
h
gene
sequenc
avail
databas
detail
analysi
h
region
present
follow
section
examin
v
l
chain
demonstr
wider
varieti
vgene
repres
six
distinct
vgene
present
suggest
larger
pool
vgene
select
compar
v
h
chain
produc
mab
specif
sarscov
case
v
h
three
jgene
famili
repres
definit
bia
toward
j
k
five
mab
even
distribut
j
k
j
k
two
mab
align
amino
acid
sequenc
v
h
v
l
chain
present
fig
inspect
v
h
sequenc
reveal
share
rel
high
level
ident
mab
convers
show
consider
higher
level
sequenc
variat
close
inspect
v
h
sequenc
show
close
relat
within
pair
amino
acid
chang
evid
sequenc
examin
v
l
sequenc
reveal
unlik
case
v
h
exhibit
consider
higher
level
sequenc
variat
case
v
h
chain
v
l
chain
pair
share
high
level
sequenc
ident
within
pair
therefor
like
clonal
relat
case
v
h
v
l
sequenc
mab
stand
least
close
relat
sequenc
panel
mab
quantit
analysi
sequenc
related
discuss
subsequ
section
discern
h
region
present
v
h
domain
show
consider
variat
align
region
avail
relat
h
region
sequenc
identifi
vquest
analysi
shown
fig
mab
contain
well
delin
shortest
hregion
high
homolog
h
gene
six
nucleotid
mab
show
high
homolog
consider
homolog
h
gene
also
overlap
mab
contain
ident
h
region
share
homolog
although
delin
region
homolog
less
clear
similarli
mab
contain
ident
h
region
homolog
manual
align
sequenc
suggest
central
portion
h
region
like
encod
element
consider
junction
divers
either
end
fig
mab
contain
h
region
homolog
discern
h
region
lack
mab
mab
therefor
includ
figur
clear
analysi
h
region
mab
highli
variabl
like
result
complex
somat
gene
rearrang
junction
diversif
assembl
examin
full
length
v
h
sequenc
outlin
fig
clear
pattern
emerg
regard
amino
acid
sequenc
ident
close
relat
v
h
sequenc
ident
ident
ident
ident
v
h
exhibit
high
level
ident
neutral
mab
show
remark
sequenc
conserv
v
h
show
high
level
sequenc
divers
one
neutral
mab
share
littl
ident
neutral
mab
deriv
differ
germlin
v
h
allel
see
follow
section
detail
analysi
mab
close
relat
v
l
sequenc
ident
ident
ident
v
l
cdr
exhibit
sequenc
variabl
found
v
h
chain
case
v
h
v
l
chain
mab
show
littl
sequenc
ident
v
l
chain
neutral
mab
fig
v
l
v
h
chain
mab
demonstr
lowest
sequenc
ident
compar
mab
panel
fig
b
averag
level
ident
heavi
light
chain
subdivid
pertin
region
shown
fig
across
full
length
v
h
evid
averag
level
ident
highest
amongst
neutral
mab
albeit
small
margin
fig
examin
v
h
cdr
reveal
exhibit
highest
level
sequenc
ident
whether
subdivid
group
contain
mab
neutral
mab
nonneutr
mab
howev
find
appar
examin
neutral
mab
whose
region
share
averag
sequenc
ident
respect
hand
exhibit
highest
sequenc
variabl
whether
group
mab
neutral
mab
nonneutr
mab
averag
level
ident
rang
extend
domain
characterist
v
h
chain
sarscov
neutral
mab
domain
neutral
mab
contain
averag
amino
acid
residu
averag
amongst
mab
residu
includ
delement
neg
clone
region
nonneutr
mab
contain
five
residu
v
l
region
exhibit
lower
averag
level
sequenc
ident
outlin
fig
v
h
sequenc
highest
averag
level
ident
across
full
length
v
l
sequenc
exhibit
neutral
mab
howev
averag
level
sequenc
ident
lower
overal
v
l
sequenc
correspond
v
h
sequenc
fig
compar
fig
b
unlik
v
h
sequenc
clear
bia
toward
higher
level
ident
cdr
three
cdr
share
rel
low
averag
sequenc
ident
regardless
group
mab
neutral
nonneutr
categori
find
suggest
v
l
cdr
like
influenc
neutral
abil
mab
lesser
extent
v
h
cdr
overal
related
v
h
v
l
sequenc
mab
quickli
summar
via
phylogenet
neighbor
join
analysi
fig
show
phylogenet
tree
gener
examin
amino
acid
sequenc
v
h
v
l
chain
fig
summar
v
h
chain
clearli
neutral
mab
cluster
togeth
close
relat
amongst
v
h
chain
least
close
relat
remain
member
group
interestingli
spikespecif
neutral
mab
cluster
apart
fact
separ
branch
tree
anoth
neutral
mab
cluster
closer
mab
nonneutr
spikespecif
mab
unfortun
protein
target
mab
current
unknown
howev
one
would
surpris
mab
fact
target
spike
interact
undetect
method
employ
thu
far
berri
et
al
although
analys
determin
whether
fact
mab
deriv
clone
clear
cluster
relat
branch
accord
overal
properti
eg
neutral
spikespecif
also
clear
mab
least
relat
mab
panel
occupi
branch
well
separ
rest
mab
examin
v
h
chain
share
highest
ident
vgene
neutral
evid
similar
pattern
emerg
monoclon
antibodi
encod
vgene
cluster
close
togeth
occupi
diverg
branch
tree
fig
essenti
pattern
emerg
examin
v
l
chain
fig
neutral
spikespecif
mab
cluster
relat
branch
occupi
separ
branch
tree
illustr
mab
least
relat
mab
panel
tabl
present
summari
level
ident
evid
group
mab
exhibit
sarscov
neutral
abil
rel
effici
neutral
mab
shown
tabl
neutral
titr
vari
low
nm
high
almost
greater
nm
comparison
recent
report
human
mab
develop
human
immun
scfv
librari
specif
angiotensin
averag
ident
b
level
ident
pairwis
express
number
ident
residuestot
number
residu
percent
ident
residu
effici
neutral
mab
neutral
titr
nm
b
averag
level
ident
calcul
valu
specifi
region
given
mab
convert
enzym
bind
domain
spike
exhibit
neutral
concentr
low
nm
sui
et
al
relationship
rest
neutral
mab
therefor
examin
attempt
identifi
common
theme
relationship
exist
amongst
clearli
mab
least
relat
neutral
mab
v
h
v
l
chain
tabl
examin
v
h
chain
averag
level
ident
compar
neutral
mab
high
across
entir
sequenc
v
h
chain
within
convers
least
close
relat
region
neutral
mab
pattern
evid
averag
level
sequenc
ident
v
h
chain
across
mab
sequenc
examin
fig
examin
v
l
chain
averag
level
ident
rest
neutral
mab
rel
low
tabl
similar
rel
low
averag
level
ident
exhibit
mab
panel
fig
averag
level
ident
v
l
lower
compar
correspond
region
v
h
exhibit
higher
averag
level
ident
v
l
chain
slightli
lower
averag
level
ident
evid
compar
howev
far
less
notic
differ
related
compar
v
h
chain
panel
mab
deriv
mice
immun
highli
purifi
whole
sarscov
exhibit
divers
specif
bind
target
variabl
vitro
neutral
abil
neutral
titr
amongst
mab
vari
lowest
nm
high
nm
interestingli
two
mab
exhibit
highest
neutral
effici
specif
spike
protein
berri
et
al
establish
conclus
spike
requir
bind
sarscov
receptor
mab
block
interact
neutral
sarscov
li
et
al
sui
et
al
result
suggest
like
neutral
sarscov
infect
directli
target
spike
although
whether
interact
spike
receptor
target
specif
remain
determin
ongo
work
answer
question
progress
although
five
mab
confirm
spikespecif
three
unabl
neutral
sarscov
infect
vitro
result
suggest
panel
mab
recogn
divers
set
epitop
within
spike
protein
region
spike
involv
viral
adhes
step
infect
process
panel
six
neutral
mab
target
four
yet
identifi
work
current
underway
determin
examin
level
pairwis
ident
neutral
mab
amino
acid
level
reveal
highest
sequenc
variabl
exhibit
v
h
surprisingli
v
h
chain
demonstr
greater
level
sequenc
ident
convers
three
cdr
v
l
chain
exhibit
similar
level
sequenc
ident
averag
lower
level
ident
correspond
v
h
region
variabl
v
h
chain
therefor
like
signific
contribut
factor
target
specif
mab
v
l
cdr
like
influenc
neutral
abil
mab
lesser
extent
v
h
cdr
averag
length
also
appear
influenc
neutral
abil
v
h
neutral
mab
contain
amino
acid
averag
number
whole
panel
mab
region
nonneutr
mab
contain
fewer
residu
convers
averag
length
v
l
constant
result
suggest
length
sequenc
v
h
influenc
neutral
abil
mab
like
determin
specif
contact
residu
key
neutral
epitop
sarscov
protein
within
group
neutral
mab
trend
evid
relat
homolog
v
h
chain
potent
neutral
mab
neutral
sarscov
less
effici
cluster
sequenc
neutral
mab
base
related
tend
correl
well
abil
neutral
sarscov
vitro
v
h
v
l
mab
lowest
neutral
effici
lowest
overal
sequenc
ident
compar
mab
compar
averag
sequenc
ident
across
whole
panel
neutral
mab
trend
appar
v
h
sequenc
sinc
percentag
ident
v
l
chain
rel
lower
overal
observ
consist
domin
role
v
h
compar
v
l
previous
identifi
neutral
mab
viral
pathogen
barba
et
al
v
h
chain
neutral
mab
close
relat
region
less
conserv
analysi
one
infer
high
homolog
v
h
rel
neutral
mab
appear
correl
neutral
abil
interestingli
exhibit
sixfold
higher
neutral
titr
even
though
sequenc
close
relat
reveal
trend
related
correl
neutral
abil
follow
mab
panel
observ
also
suggest
small
chang
amino
acid
composit
mab
significantli
alter
neutral
effici
overal
analysi
clearli
demonstr
v
h
region
neutral
mab
highli
relat
v
l
chain
suggest
sequenc
v
l
chain
play
smaller
role
neutral
abil
v
h
chain
analysi
sequenc
mab
reveal
v
h
v
l
chain
sever
mab
close
relat
pair
exhibit
differ
amino
acid
level
within
pair
observ
could
explain
sever
way
first
pair
might
origin
b
cell
progenitor
clonal
relat
fish
et
al
observ
sequenc
variat
result
somat
mutat
second
ident
rearrang
might
occur
b
cell
progenitor
antigen
select
may
produc
sever
independ
rearrang
close
relat
b
cell
clone
third
altern
sequenc
chang
might
occur
revers
transcript
pcr
amplif
mab
origin
independ
pick
hybridoma
clone
analys
allow
differenti
potenti
caus
high
sequenc
similar
would
specul
first
explan
like
true
v
h
chain
eight
mab
belong
vgene
famili
six
mab
neutral
sarscov
vitro
result
suggest
small
pool
b
cell
express
relat
ig
vgene
select
respons
exposur
sarscov
entir
surpris
consid
vgene
famili
estim
contain
sever
hundr
member
genom
balbc
mous
livant
et
al
famili
highli
select
murin
b
cell
hain
et
al
clear
restrict
pool
v
h
gene
select
encod
sarscov
neutral
mab
bia
toward
select
gene
vgene
famili
gener
autoantibodi
tightskin
mous
also
report
kasturi
et
al
j
h
gene
usag
distribut
rel
evenli
mab
gener
work
agre
well
observ
j
h
gene
usag
sever
murin
innat
antibodi
belong
vgene
famili
approxim
evenli
distribut
seidl
et
al
result
suggest
typic
varieti
join
j
gene
select
gener
v
h
chain
clone
convers
bia
evid
select
j
gene
gener
v
l
chain
clone
agre
publish
report
preferenti
select
j
k
j
k
gene
adult
mous
splenic
cell
wood
coleclough
nishi
et
al
observ
suggest
v
l
chain
mab
appear
deriv
divers
pool
v
gene
may
less
critic
contribut
contact
residu
rel
v
h
bind
sarscov
protein
complet
absenc
h
region
result
small
vdomain
two
nonneutr
spikespecif
mab
suggest
region
contribut
significantli
neutral
divers
length
sequenc
appar
order
assembl
h
region
present
mab
suggest
signific
somat
alter
sequenc
flank
h
region
occur
junction
assembl
somat
mutat
occur
affin
matur
germin
center
presenc
ident
h
element
region
support
notion
pair
clonal
relat
deriv
parent
vgene
rearrang
summari
multipl
mab
abl
neutral
sarscov
infect
vitro
gener
work
display
neutral
titr
nanomolar
picomolar
rang
major
v
h
chain
neutral
mab
share
signific
homolog
ig
vgene
famili
suggest
select
limit
pool
vgene
occur
mice
expos
highli
purifi
sarscov
high
level
sequenc
ident
v
h
chain
compar
low
level
sequenc
ident
v
l
chain
suggest
neutral
abil
impart
mab
contact
residu
within
v
h
chain
chain
shuffl
experi
employ
determin
rel
contribut
v
h
v
l
chain
sarscov
neutral
berri
et
al
passiv
immun
therapi
viabl
treatment
exposur
numer
virus
develop
mab
report
import
first
step
isol
mab
gener
intact
sar
viru
could
use
passiv
immunotherapi
human
murin
mab
viabl
method
develop
potenti
passiv
immunotherapeut
roguska
et
al
rader
et
al
method
appli
mab
develop
work
one
caveat
analysi
exhaust
statist
analysi
relationship
mab
describ
due
small
number
mab
examin
trend
gener
relationship
regard
level
sequenc
ident
mab
immunolog
properti
infer
regardless
analysi
provid
use
summari
murin
mab
possess
potenti
develop
viabl
immun
therapi
diagnost
tool
sarscov
infect
recurr
usag
particular
murin
vgene
element
encod
virusneutr
antibodi
becom
evid
detail
molecular
analys
becom
avail
kalink
et
al
studi
anim
model
current
underway
determin
vivo
neutral
properti
neutral
mab
summar
